Gilead Profit Soars Into The Billions, Fueled By Hepatitis C Drug That Costs $1,000 Per Pill
The maker of a hepatitis C drug that costs about $1,000 per pill on Wednesday delivered a quarterly earnings report that shattered expectations, showing the company tripled its profit which is now in the billions.
